Clin2
NCT07679113Likely a fitRecruiting

IPG1094 drug safety test in healthy Chinese adults

Healthy Volunteers

This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • Be a healthy Chinese adult between 18 and 50 years old.
  • Weigh at least 50 kg if male, or 45 kg if female, with a BMI between 19 and 26.
  • Have normal test results for your heart, lungs, and lab work, or only minor findings that the doctor says are okay.
  • Not be pregnant, nursing, or planning a pregnancy; use effective birth control from 2 weeks before screening to 6 months after the study ends.
  • Be willing to follow the study rules, including avoiding certain foods, drinks, and medications as directed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07311811Not yet recruiting· Phase 1
Study of two new drugs in healthy volunteers

This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.

Seoul
NCT07448194Recruiting· Phase 1
Safety study of HW241045 in healthy adults

This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.

Beijing
NCT06839131Recruiting· Phase 1
Study of SPH9788 tablets in healthy Chinese volunteers

This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.

Shanghai
NCT07535099Recruiting· Phase 1
Safety study of ICP-538 in healthy volunteers

This trial tests a new drug called ICP-538 in healthy people to see how safe it is and how the body processes it. It is an early-phase study that helps decide if the drug can move to testing in patients with a specific condition.

Beijing, Beijing Municipality
NCT06926218Not yet recruiting· Phase 1
Safety study of HSK47388 in healthy adults

This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.

Adelaide
NCT07745907Recruiting· Phase 1
A first-in-human study of a new drug in healthy Chinese and Japanese adults

This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.

Las Vegas, Nevada

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.